The association of increased soluble VCAM-1 levels with CMV disease in human kidney allograft recipients.
Lebranchu
Y
Y
Nephrologie-Immunologie Clinique, Hôpital Bretonneau, CHU Tours France.
al Najjar
A
A
Kapahi
P
P
Valentin
J F
JF
Nivet
H
H
Bagros
P
P
Bardos
P
P
Haskard
D
D
D015415:Biomarkers / Q000097:blood; D015815:Cell Adhesion Molecules / Q000096:biosynthesis* / Q000097:blood; D003586:Cytomegalovirus Infections / Q000097:blood* / Q000175:diagnosis; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D011183:Postoperative Complications / Q000097:blood / Q000175:diagnosis; D014184:Transplantation, Homologous; D019010:Vascular Cell Adhesion Molecule-1
D015415:Biomarkers; D015815:Cell Adhesion Molecules; D007166:Immunosuppressive Agents; D019010:Vascular Cell Adhesion Molecule-1